%D0%95%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D1%87%D0%B5%D0%BD_%D0%BA%D0%BE%D0%BD%D1%8E%D0%BD%D0%BA%D1%82%D0%B8%D0%B2%D0%B8%D1%82Category:KeratoconjunctivitisKeratoconjunctivitis%DA%A9%D8%B1%D8%A7%D8%AA%D9%88%DA%A9%D9%86%DA%98%D9%86%DA%A9%D8%AA%DB%8C%D9%88%DB%8C%D8%AAK%C3%A9ratoconjonctiviteCheratocongiuntivite%E8%A7%92%E7%B5%90%E8%86%9C%E7%82%8E%EA%B0%81%EA%B2%B0%EB%A7%89%EC%97%BC%D0%9A%D0%B5%D1%80%D0%B0%D1%82%D0%BE%D0%BA%D0%BE%D0%BD%D1%8A%D1%8E%D0%BD%D0%BA%D1%82%D0%B8%D0%B2%D0%B8%D1%82KeratokonjonktivitCoirn%C3%AAyi-djontiviteQ1623006
about
Safety and Efficacy of KPI-121 in Subjects With DEDEffect of B-cell Depletion in Patients With Primary Sjögren's SyndromeCyclosporin A Eye Drop Treatment in Vernal KeratoconjunctivitisLactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis TreatmentDry Eye Assessment and Management: Feasibility StudyEfficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)DRy Eye Outcome and Prescription StudyA Phase I Study of PP-001 Eye Drops in Healthy Adult VolunteersClinical, Meibographic and Interferometric Evaluation of Phlyctenular Keratitis in Children - MEIBO-ROSACEEEffect of Controlled Adverse Environment (CAE) on Tear Film StabilitySafety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)Trial of CF101 to Treat Patients With Dry Eye DiseaseRepository Corticotropin Injection in Keratoconjunctivitis SiccaEffects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye DiseaseKinetic Oscillation Stimulation (KOS) as a Treatment of Keratoconjunctivitis Sicca (Dry Eye Syndrome)An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis SiccaPhase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis SiccaTavilermide Ophthalmic Solution for the Treatment of Dry EyeOcular Manifestations in Rheumatic DiseasesDiadenosine Polyphosphates and Mucin Associated With Ocular Surface DisordersTear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye DropsEfficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry EyeTreatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye DiseaseA Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye SyndromeA Study Of Tasocitinib In Dry Eye SubjectsTopical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in RwandaTreatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodineSafety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry EyeDouble-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal KeratoconjunctivitisPhase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis SiccaLevocarnitine for Dry Eye in Sjogren's SyndromeA Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry EyeLaser Therapy to Treat the Dry Mouth of Sjogren's SyndromeCytokine Assay in Tears of Healthy Children and With Vernal Keratoconjunctivitis: Case Control Study and Monitoring of Cases at 6 MonthsEfficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)Three Dimension Tomography of Eye Structures by White Light Imaging DeviceSafety and Efficacy of KPI-121 in Subjects With Dry Eye DiseaseLotemax® Gel 0.5% and Restasis 0.05% in Subjects With Mild or Moderate Keratoconjunctivitis Sicca
P1050
P279
Allergic conjunctivitis: a comprehensive review of the literature.Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products.Adenoviral keratoconjunctivitisCLINICAL AND VIROLOGIC STUDIES ON THE FIRST WIDESPREAD OUTBREAK OF EPIDEMIC KERATOCONJUNCTIVITIS IN HUNGARYA HOSPITAL EPIDEMIC OF KERATOCONJUNCTIVITIS CAUSED BY ADENOVIRUS TYPE 7 IN HELSINKI[LATE COURSE OF THE TYPE 8 ADENOVIRUS INFECTION ASSOCIATED WITH ROENTGENOLOGICAL CHANGES IN THE LUNG][EPIDEMIC KERATOCONJUNCTIVITIS]EPIDEMIC KERATOCONJUNCTIVITIS ON TAIWAN: ETIOLOGICAL AND CLINICAL STUDIES[CONJUNCTIVITIS DUE TO APC VIRUS; WORK ACCIDENT][ISOLATION OF VIRUSES AND SEROLOGICAL TESTS IN THE 1962 KERATOCONJUNCTIVITIS EPIDEMIC IN SZEGED][THE EFFECT OF IUDR (5-IODO-2'-DESOXYURIDINE) ON THE ADENOVIRUS 8 (CLINICAL AND LABORATORY EXPERIENCES).]TREATMENT OF EPIDEMIC KERATO-CONJUNCTIVITIS WITH LOCAL INSTILLATION OF CONVALESCENT SERUMSTUDIES ON THE ANTIVIRAL ACTIVITY OF DISTAMYCIN A[IMPORTANCE OF THE HEMAGGLUTINATION INHIBITION REACTION IN THE DIAGNOSIS OF EPIDEMIC KERATOCONJUNCTIVITIS]HISTOLOGICAL FINDINGS IN EPIDEMIC KERATOCONJUNCTIVITIS[STUDIES ON AN EPIDEMIC OF KERATOCONJUNCTIVITIS CAUSED BY ADENOVIRUS TYPE 8. II. CLINICAL AND EPIDEMIOLOGICAL STUDIES][ON EPIDEMIC KERATOCONJUNCTIVITIS][Laboratory infection with adenovirus type 8.]Infections due to adenovirus type 8 in the United States. II. Community-wide infection with adenovirus type 8[On the etiology of keratoconjunctivitis epidemica at Szeged, Hungary in 1962.][Pathological study of keratoconjunctivitis epidemica in Budapest in the winter of 1961-62.]Isolation of adenoviruses from cases of epidemic keratoconjunctivitis in SingaporeHETEROTYPIC HAEMAGGLUTINATION INHIBITION IN THE ADENOVIRUS GROUPSOME BIOLOGICAL CHARACTERISTICS OF ADENOVIRUS TYPE 8 STRAINSACCIDENTAL LABORATORY INFECTIONS BY ADENOVIRUS TYPE 8STUDIES ON THE AETIOLOGY OF EPIDEMIC KERATOCONJUNCTIVITIS OBSERVED IN BUDAPEST DURING WINTER, 1961--1962Epidemic kerato-conjunctivitis in MalayaClinical and viral studies of cases of epidemic keratoconjunctivitis in SingaporeAdenovirus type 8 and the story of epidemic keratoconjunctivitis[Epidemic keratoconjunctivitis as an APC virus infection]
P921
Q61904797-991B2B0B-EA91-4659-BF57-F5AF97741BA5Q61921426-CA72CC5D-8D82-4286-9F83-00C3E09A3B88Q61921465-A7123F3A-3141-4E28-B993-28BD5B5F02FBQ61924653-D866AD83-DECB-43A6-BC36-3D9AED6BB0C7Q61935924-BB2BCDB9-EE36-43F7-8229-2C9AE3431CF7Q61939065-C0A84CFA-A2C6-45DC-B798-5E514136CDDCQ62025262-B6CACC37-4BF1-4CD1-837B-557CE3849268Q62031468-F8E13C43-D5FA-4108-BAEC-D4F9A6B83484Q62811673-CE2519FE-D834-47FC-B2C8-10A4735EC34CQ63316528-E1B1C634-2A44-43C4-9A32-2F112A14D7A5Q63322083-59E56EE1-B620-43E6-AA23-8CFD307AE84EQ63340768-4F8DB214-E8C1-4840-9BDA-B4AB75DE8541Q63402972-97A3D772-73F3-415B-A262-77F5F032BC2FQ63403732-FC03316C-89A0-475B-A63E-18490378DC54Q63404238-4D618A6A-DA3D-451B-9AB4-383FC6EB4C83Q63577606-18FF8865-6C75-40DC-85C1-58159D8C5AAFQ63578243-6C292600-7F0A-4400-9947-3378BA3E71C3Q63587023-5BD1B8A5-01DC-4681-BD45-C724AF2A27DEQ63594751-5BD5D6E4-A80A-4099-9F3D-AF005A17A78EQ63595816-499BA75B-C5FA-43E9-8A7A-9574FD83FB07Q63599519-654364F5-BA80-42DF-9C5C-DAF7ED214242Q63613249-A3656679-028A-4C42-87EA-F85BFF14BF64Q63808342-47BFFBC6-682B-4583-B82B-4BB368B03369Q63813335-45764B25-4CD0-43A4-A07F-A186CF42A751Q63816855-C85C6F56-D62E-4C08-888E-20EB98A60261Q63819246-B33DBAED-50C6-4194-BF8F-BFF109F9107DQ63829200-75FA20DF-6026-4025-B3F6-50A94F07FD59Q63838762-826E97A9-9413-4CBF-8468-1D6B052F0D9DQ63840437-860C984F-98E7-4A97-A2EB-F88C8825E2DCQ64139603-70026FD9-74C8-4CB2-97B0-4012F5F8A3E9Q64149990-987312EE-D40D-453C-9BC6-913683FCAB5DQ64171076-E2B1D83A-9BB0-4A6F-A534-1A6BADF0D0E3Q64222988-0D1E7851-A916-400F-B6D7-CD02F2872E3EQ64336043-6FFFA5ED-0B96-4285-8C04-3A34E710D24FQ64336819-81EB5271-743A-42B6-B050-2C1C9B2004CEQ64352812-DEC579B8-B9C9-44BA-8B43-FC1813A8EAA1Q64363629-01B2B713-5FA0-4198-A3C8-67B67BA8AAC5Q64395459-83C43443-A8F5-40C4-9B4F-C5B5C476454FQ64607833-5A2B2350-2738-4ABA-8E7E-DD61574A500EQ64625414-BE89F876-A13A-4F50-B92B-3628FC506EED
P1050
Q1117652-04988D3A-B723-48EF-BE09-C4DC5B3F32C7Q1162694-CB0FC124-BA8B-4909-BD72-D4F749FD77D4Q18554243-FF7D6DCA-F8F6-4833-B136-7492F712D072Q18558134-7393BAFB-D3F9-44C0-B275-8A8FC00C131EQ19001207-cecbe323-47f7-7785-747d-7062553c42d0Q19001242-1867a085-4d0a-e9b2-1357-e352394f894cQ7186555-EC23A90C-C201-4D87-BE97-F8ED73BDEF11Q7643645-0a6d00f5-4793-83ed-bab9-84f5b4aa4a61Q769741-9E8C7979-8E50-498D-A10E-E0211D3726E9Q8627-00C3C7F1-39A5-4AFE-957B-E66549DE1CCF
P279
description
Kornearen eta konjuntibaren aldibereko hantura
@eu
Krankheit
@de
infection qui se traduit par u ...... ctive et de la cornée de l’œil
@fr
infiammazione che riguarda l'occhio (sia della cornea che della congiuntiva).
@it
inflammation ("-itis") of the cornea and conjunctiva.
@en
zánětlivé onemocnění spojivky
@cs
مرض يصيب الإنسان
@ar
name
Coirneyi-djontivite
@wa
Keratokonjonktivit
@tr
cheratocongiuntivite
@it
keratoconjunctivitis
@en
keratokonjunktivitida
@cs
keratokonjunktivitt
@nn
keratokonjuntibitis
@eu
kératoconjonctivite
@fr
llid y gornbilen a'r gyfbilen
@cy
Епидемичен конюнктивит
@bg
type
label
Coirneyi-djontivite
@wa
Keratokonjonktivit
@tr
cheratocongiuntivite
@it
keratoconjunctivitis
@en
keratokonjunktivitida
@cs
keratokonjunktivitt
@nn
keratokonjuntibitis
@eu
kératoconjonctivite
@fr
llid y gornbilen a'r gyfbilen
@cy
Епидемичен конюнктивит
@bg
altLabel
Cheratocongiuntiviti
@it
certain types of keratoconjunctivitis
@en
keratitt med konjunktivitt
@nn
keratitt og konjunktivitt
@nn
kerato-conjunctivitis
@en
keratokonjunktivitis
@cs
zánět spojivky
@cs
Конюнктивит
@bg
کراتوکونژنکتیویت
@fa
prefLabel
Coirneyi-djontivite
@wa
Keratokonjonktivit
@tr
cheratocongiuntivite
@it
keratoconjunctivitis
@en
keratokonjunktivitida
@cs
keratokonjunktivitt
@nn
keratokonjuntibitis
@eu
kératoconjonctivite
@fr
llid y gornbilen a'r gyfbilen
@cy
Епидемичен конюнктивит
@bg
P1692
P2176
P279
P2888
P486
P508
P6366
P646
P1417
science/keratoconjunctivitis
P1692
P1748
P1995
P2892
P31
P373
Keratoconjunctivitis
P3827
keratoconjunctivitis
P3841
HP:0001096